Anti-Human CD27 Therapeutic Antibody (Varlilumab)
Recombinant human antibody to Human CD27. Varlilumab is an immunotherapy designed to enhance the body's natural immune response by directly activating T cells that can specifically recognize and kill cancer cells.
Supplier | Creative Biolabs |
---|---|
Product # | TAB-H74 |
Pricing | Inquiry |
Host | human |
Target | CD27 |
Species Reactivity | Human |
Type | IgG1 - kappa |
Applications | ELISA, IP, FC, FuncS, Neut, IF, ICC |